Benefits and costs of expanding access to family planning programs to women living with HIV

AIDS

Volumn 23, Issue SUPPL. 1, 2009, Pages

  Halperin, Daniel T ^a   Stover, John ^b   Reynolds, Heidi W ^c  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b AVENIR HEALTH   (United States)

^c UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL   (United States)

Author keywords

Developing countries; Family planning services; HIV prevention; Prevention of mother to child HIV transmission

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; LAMIVUDINE; NEVIRAPINE; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; ADULT; ARTICLE; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DRUG EFFICACY; FAMILY PLANNING; FEMALE; HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH PROGRAM; HEALTH SERVICE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; MAJOR CLINICAL STUDY; PERINATAL INFECTION; PREGNANT WOMAN; PRIORITY JOURNAL; UNPLANNED PREGNANCY; VIRUS TRANSMISSION;

ADULT; COST-BENEFIT ANALYSIS; DEVELOPING COUNTRIES; FAMILY PLANNING SERVICES; FEMALE; HEALTH SERVICES ACCESSIBILITY; HIV INFECTIONS; HUMANS; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; PREGNANCY;

EID: 72249113393     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/01.aids.0000363785.73450.5a     Document Type: Article

References (44)

1. World Health Organization. Toward universal access. Scaling up priority HIV/AIDS interventions in the health sector. Progress report 2008. Geneva, Switzerland: WHO; 2008
2. DeCock KM, Fowler MG, Mercier E, de Vincenzi I, Saba J, Hoff E, et al. Prevention of mother-to-child HIV transmission in resource-poor countries: translating research into policy and practice. JAMA 2000; 283:1175-1182 (Pubitemid 30126606)
3. World Health Organization. Strategic approaches to the prevention of HIV infection in infants: report of a WHO meeting; Morges, Switzerland, 20-22 March 2002. Geneva, Switzerland: WHO; 2003
4. Sweat MD, O'Reilly KR, Schmid GP, Denison J, de Zoysa I. Cost-effectiveness of nevirapine to prevent mother-to-child HIV transmission in eight African countries. AIDS 2004; 18:1661-1671
5. International Treatment Preparedness Coalition. Missing the target: failing women, failing children-HIV, vertical transmission and women's health. The International Treatment Preparedness Coalition (ITPC); 2009. http://www.aidstreatmen taccess.org/mtt7-final.pdf. [Accessed 29 August 2009]
6. World Health Organization. Guidance on global scale-up of the prevention of mother to child transmission of HIV: towards universal access for women, infants and young children and eliminating HIV and AIDS among children. Inter-Agency Task Team on Prevention of HIV Infection in Pregnant Women, Mothers and their Children. Geneva, Switzerland: WHO; 2007
7. Guay LA, Musoke P, Fleming T, Bagenda D, Allen M, Nakabiito C, et al. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial. Lancet 1999; 354:795-802
8. Marseille E, Kahn JG, Mmiro F, Guay L, Musoke P, Fowler MG, Jackson JB. Cost effectiveness of single-dose nevirapine regimen for mothers and babies to decrease vertical HIV-1 transmission in sub-Saharan Africa. Lancet 1999; 354:803-809
9. World Health Organization. Toward universal access. Scaling up priority HIV/AIDS interventions in the health sector. Progress report 2008. Geneva, Switzerland: WHO; 2008
10. United Nations. Declaration of commitment on HIV/AIDS United Nations General Assembly special session on HIV/AIDS; 25-27 June 2001
11. Rutenberg N, Baek C. Field experiences integrating family planning into programs to prevent mother-to-child transmission of HIV. Stud Fam Plann 2005; 36:235-245 (Pubitemid 41801173)
12. Strachan M, Kwateng-Addo A, Hardee K, Subramaniam S, Judice N, Agarwal K. An analysis of family planning content in HIV/AIDS, VCT, and PMTCT policies in 16 countries. POLICY working paper series no. 9. Washington, District of Columbia, USA: POLICY Project; 2004
13. Sedgh G,Hussain R, Bankole A, Singh S.Women withan unmet need for contraception in developing countries and their reasons for not using a method. Occasional report no. 37. New York: Guttmacher Institute; 2007
14. Adair T. Desire for children and unmet need for contraception among HIV-positive women in Lesotho. DHS working papers. Calverton, Maryland, USA: Macro International; 2007
15. Chersich MF, Luchters SM, Yard E, Othigo JM, Kley N, Temmer-man M. Morbidity in the first year postpartum among HIV-infected women in Kenya. Int J Gynecol Obstet 2008; 100:45-51
16. Homsy J, Bunnell R, Moore D, King R, Malamba S, Nakityo R, et al. Incidence and determinants of pregnancy among women receiving ART in rural Uganda (abstract #74). Conf Retrovir Opportunistic Infect 2008;15
17. Bangendanye L. Pregnancy, pregnancy desires, and contraceptive use among HIV-infected women. Findings from a survey of women enrolled in PMTCT in Rwanda. Presentation at the 3rd Annual Pediatric Conference on the Infected and Affected by HIV and AIDS, Kigali, Rwanda; December 2007
18. Desgrées-du-Loû A, Msellati P, Viho I, Yao A, Yapi D, Kassi P, et al. Contraceptive use, protected sexual intercourse and incidence of pregnancies among African HIV-infected women. DITRAME ANRS 049 Project, Abidjan 1995-2000. Int J STD AIDS 2002; 13:462-468
19. Hoffman IF, Martinson FEA, Powers KA, Chilongozi DA, Msiska ED, Kachipapa EI, et al. The year-long effect of HIV-positive test results on pregnancy intentions, contraceptive use, and pregnancy incidence among Malawian women. J Acquir Immune Defic Syndr 2008; 47:477-483
20. Reynolds HW, Steiner MJ, Cates W Jr. Contraception's proved potential to fight HIV. Sex Transm Inf 2005; 81:184-185
21. Reynolds HW, Janowitz B, Wilcher R, Cates W. Contraception to prevent HIV-positive births: current contribution and potential cost saving in PEPFAR countries. Sex Transm Infect 2008; 84 (Suppl II):ii49-ii53
22. Reynolds HW, Janowitz B, Homan R, Johnson L. The value of contraception to prevent perinatal HIV transmission. Sex Transm Dis 2006; 33:350-356
23. Alan Guttmacher Institute. World population day: six reasons to support family planning. 9 July 2008. http://www.guttmacher.-org/media/inthenews/2008/ 07/09/index.html
24. Joint United Nations Programme on HIV/AIDS (UNAIDS). 2008 Report on the global health epidemic. Geneva, Switzerland: WHO 2009.
25. World Health Organization (WHO). Antiretroviral drugs for treating pregnant women and preventing HIV infection in infants: towards universal access. Recommendations for a public health approach. Geneva, Switzerland: WHO; 2006
26. Stover J, Johnson P, Zaba B, Zwahlen M, Dabis F, Ekpini RE. The Spectrum projection package: improvements in estimating mortality, ART needs, PMTCT impact and uncertainty bounds. Sex Transm Inf 2008; 84 (Suppl 1):i24-i30. doi:10.1136/ sti.2008.029868
27. Kuhn L, Reitz C, Abrams EJ. Breastfeeding and AIDS in the developing world. Curr Opin Pediatr 2009; 21:83-93
28. Joint United Nations Programme on HIV/AIDS (UNAIDS). Global resource needs report: financial resources required to achieve universal access to HIV prevention, treatment, care and support. Geneva, Switzerland: UNAIDS 2007.
29. Bongaarts J. 'The fertility-inhibiting effects of the intermediate fertility variables'. Stud Fam Plann 1982; 13:179-189
30. Stover J, Heaton L, Ross J. FamPlan Version 4. A computer program for projecting family planning requirements. Washington, District of Columbia, USA: Future Group; 2006
31. United Nations Population Division. World population prospects: the 2008 revision. New York, USA: United Nations 2009.
32. Hogan DR, Baltussen R, Hayashi C, Lauer JA, Salomon JA. Cost effectiveness analysis of strategies to combat HIV/AIDS in developing countries. BMJ 2005; 331:1431-1437
33. Marseille E, Morin SF, Collins C, Summers T, Coates TJ, Kahn JG. Cost-effectiveness of HIV prevention in developing countries. HIV insite knowledge base chapter; 2002. http://hivinsite.ucsf. edu/InSite?page=kb-08-01- 04. [Accessed 27 December 2007]
34. Stringer JSA, Rouse DJ, Vermund SH, Goldenberg RL, Sinkala M, Stinnett AA. Cost-effective use of nevirapine to prevent vertical HIV transmission in sub-Saharan Africa. J Acquir Immune Defic Syndr 2000; 24:369-377
35. Katz KR, West CG, Doumbia F, Kane F. Increasing access to family planning services in rural Mali through community-based distribution. Int Fam Plann Perspect 1998; 24:104-110
36. Luck M, Jarju E, Nell MD, George MO. Mobilizing demand for contraception in rural Gambia. Stud Fam Plann 2000; 31:325-335
37. Chege J, Rutenberg N, Janowitz B, Thompson A. Factors affecting the outputs and costs of community-based distribution of family planning services in Tanzania. New York, New York, USA: Population Council and Family Health International; 1998
38. Kiarie JN, Kreiss JK, Richardson BA, John-Stewart GC. Compliance with antiretroviral regimens to prevent perinatal HIV-1 transmission in Kenya. AIDS 2003; 17:65-71
39. Temmerman M, Quaghebeur A, Mwanyumba F, Mandaliya K. Mother-to-child HIV transmission in resource poor settings: how to improve coverage? AIDS 2003; 17:1239-1242
40. Meda N, Leroy V, Viho I, Msellati P, Yaro S, Mandelbrot L, et al. Field acceptability and effectiveness of the routine utilization of zidovudine to reduce mother-to-child transmission of HIV-1 in West Africa. AIDS 2002; 16:2323-2328
41. Malonza IM, Richardson BA, Kreiss JK, Bwayo JJ, Stewart GC. The effect of rapid HIV-1 testing on uptake of perinatal HIV-1 interventions: a randomized clinical trial. AIDS 2003; 17:113-118
42. Kongnyuy EJ, Wiysonge CS. Association between fertility and HIV status: what implications for HIV estimates. BMC Public Health 2008; 8:309. doi:10.1186/1471-2458/8/309
43. Singh S, Darroch JE, Vlassoff M, Nadeau J. Adding it up. The benefits of investing in sexual and reproductive healthcare. New York, New York, USA: Alan Guttmacher Institute; 2004
44. Potts M, Halperin DT, Kirby D, Swidler A, Marseille E, Klausner JD, et al. Reassessing HIV prevention. Science 2008; 320:749-750